Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Neogen ChemicalsNSE:NEOGEN -0.34%87 EV-to-EBITDA is 47.13 as of Sep. 17, 2026, which is 38% above its 10-year median of 34.21. GuruFocus rates NSE:NEOGEN with a GF Score™ of 87/100 and a GF Value™ of ₹2,117.60 (Fairly Valued). The stock has 12 warning signs investors should review. Among 1,409 Chemicals companies, Neogen Chemicals ranks worse than 89.14% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Neogen Chemicals's enterprise value is ₹76,933 Mil.
Neogen Chemicals's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ₹1,633 Mil. Therefore, Neogen Chemicals's EV-to-EBITDA for today is 47.13.
The historical rank and industry rank for Neogen Chemicals's EV-to-EBITDA or its related term are showing as below:
NSE:NEOGEN'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 13.08 Med: 34.21 Max: 61.09
Current: 47.13
During the past 13 years, the highest EV-to-EBITDA of Neogen Chemicals was 61.09. The lowest was 13.08. And the median was 34.21.
NSE:NEOGEN's EV-to-EBITDA is ranked worse than 89.14% of 1409
companies
in the Chemicals industry
Industry Median: 11.25
vs NSE:NEOGEN: 47.13
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Neogen Chemicals's PE Ratio (TTM) for today is calculated as:
Neogen Chemicals's share price for today is ₹2302.40.
Neogen Chemicals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹13.242.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Neogen Chemicals's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:NEOGEN vs LIN, SHW, ECL: EV-to-EBITDA Comparison
For the Specialty Chemicals subindustry, Neogen Chemicals's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neogen Chemicals EV-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Neogen Chemicals's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Neogen Chemicals's EV-to-EBITDA falls into.
Neogen Chemicals's current Enterprise Value is ₹76,933 Mil.
Neogen Chemicals's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,633 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neogen Chemicals (NSE:NEOGEN) has a EV-to-EBITDA of 47.13 as of Sep. 17, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Neogen Chemicals. This is 38% above median its historical median of 34.21. Over the past decade, Neogen Chemicals' EV-to-EBITDA has ranged from 13.08 to 61.09. According to the industry distribution chart, Neogen Chemicals ranks #1256 out of 1409 companies in the Chemicals industry, placing it in the top 89.1%.
Is Neogen Chemicals' EV-to-EBITDA too high?
Neogen Chemicals' current EV-to-EBITDA of 47.13 is 38% above median its 10-year median of 34.21. Over the past 10 years, this metric has ranged from a low of 13.08 to a high of 61.09. The Chemicals industry median EV-to-EBITDA is 11.25. Neogen Chemicals' value of 47.13 is 318.9% above this industry median. Based on the distribution chart, Neogen Chemicals ranks #1256 out of 1409 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Neogen Chemicals has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Neogen Chemicals' EV-to-EBITDA compare to LIN and SHW?
According to the Chemicals industry distribution chart, Neogen Chemicals ranks #1256 out of 1409 companies for EV-to-EBITDA. This places Neogen Chemicals in the lower half of its industry. The industry median EV-to-EBITDA is 11.25. Neogen Chemicals' value of 47.13 is 318.9% above this benchmark. Historically, Neogen Chemicals' own EV-to-EBITDA has ranged from 13.08 to 61.09 over the past decade. While the company's 10-year median is 34.21 vs. the industry median of 11.25, Neogen Chemicals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Chemicals company?
The median EV-to-EBITDA among Chemicals companies is 11.25, based on 1,409 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neogen Chemicals's current EV-to-EBITDA of 47.13 is 318.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Neogen Chemicals. For the Chemicals industry, the median EV-to-EBITDA is 11.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neogen Chemicals's current EV-to-EBITDA is 47.13, which is 38% above median its own 10-year median of 34.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neogen Chemicals stock overvalued right now?
Based on GuruFocus' analysis, Neogen Chemicals (NSE:NEOGEN) is currently considered Fairly Valued. The stock's GF Value™ is ₹2,117.60, compared to a current price of ₹2,302.40 — trading 8.7% above its estimated fair value. The current EV-to-EBITDA is 47.13, which is 38% above median its 10-year median of 34.21 and 318.9% above the Chemicals industry median of 11.25. Neogen Chemicals' overall GF Score™ is 87/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Neogen Chemicals (NSE:NEOGEN), the current EV-to-EBITDA is 47.13 as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neogen Chemicals (NSE:NEOGEN) Overvalued in 2026?
Based on GuruFocus' analysis, Neogen Chemicals stock appears to be overvalued.
The current stock price of ₹2,302.40 is trading 8.7% above its estimated GF Value™ of ₹2,117.60.
GuruFocus considers Neogen Chemicals to be Fairly Valued.
Key valuation signals for NSE:NEOGEN:
EV-to-EBITDA: 47.13 (38% above median its 10-year median of 34.21)
GF Value™: ₹2,117.60 vs. price of ₹2,302.40 (8.7% above fair value)
Industry Position: 318.9% above the Chemicals median (#1256 of 1409)
No single metric tells the full story. See the NSE:NEOGEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neogen Chemicals Ltd is engaged in the manufacturing of specialty chemicals that are used in the Pharmaceutical, Engineering and Agro-Chemical industries. The company manufactures bromine-based and lithium-based specialty chemicals. Its products include Organobromine compounds, Chloro compounds, Inorganic bromine compounds, Lithium Salts and others. Geographically, It generates the majority of the revenue from India and also exports to other countries.
87GF Score
Get the complete analysis for NSE:NEOGEN
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NEOGEN has been successfully added to your 
